Valuation IDEXX Laboratories, Inc. Sao Paulo
Stocks
I1DX34
BRI1DXBDR001
Medical Equipment, Supplies & Distribution
|
Market Closed -
Sao Paulo
02:54:36 05/11/2026 HKT
|
5-day change | 1st Jan Change | ||
| 777.80 BRL | +4.53% |
|
+25.43% | +2.98% |
| 11-06 | Rising vet bills drive more Americans to pet insurance | RE |
| 11-05 | Rising vet bills drive more Americans to pet insurance | RE |
Company Valuation: IDEXX Laboratories, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 55,833 | 33,786 | 46,098 | 33,854 | 54,022 | 53,263 | - | - |
| Change | - | -39.49% | 36.44% | -26.56% | 59.57% | -1.41% | - | - |
| Enterprise Value (EV) 1 | 56,612 | 35,022 | 46,592 | 34,434 | 54,690 | 53,658 | 53,119 | 52,615 |
| Change | - | -38.14% | 33.04% | -26.09% | 58.83% | -1.89% | -1.01% | -0.95% |
| P/E | 76.6x | 50.8x | 55.2x | 38.7x | 51.7x | 45x | 40.2x | 35.4x |
| PBR | 82.6x | 55.6x | 31x | 21.6x | 34.1x | 27x | 19.8x | 14.5x |
| PEG | - | -7.66x | 2.2x | 6.38x | 2.3x | 3x | 3.4x | 2.6x |
| Capitalization / Revenue | 17.4x | 10x | 12.6x | 8.69x | 12.6x | 11.2x | 10.3x | 9.42x |
| EV / Revenue | 17.6x | 10.4x | 12.7x | 8.83x | 12.7x | 11.3x | 10.3x | 9.3x |
| EV / EBITDA | 54.6x | 34.7x | 38.4x | 28.1x | 36.3x | 31.7x | 28.4x | 25.3x |
| EV / EBIT | 60.7x | 39x | 42.5x | 30.5x | 40.2x | 35x | 31.2x | 27.6x |
| EV / FCF | 89x | 88.9x | 60.3x | 42.6x | 51.7x | 46.7x | 40.5x | 35.6x |
| FCF Yield | 1.12% | 1.13% | 1.66% | 2.35% | 1.93% | 2.14% | 2.47% | 2.81% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | 8.6 | 8.03 | 10.06 | 10.67 | 13.08 | 15.04 | 16.81 | 19.1 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 3,215 | 3,367 | 3,661 | 3,898 | 4,304 | 4,753 | 5,174 | 5,657 |
| EBITDA 1 | 1,037 | 1,011 | 1,212 | 1,225 | 1,505 | 1,694 | 1,869 | 2,079 |
| EBIT 1 | 932 | 898.8 | 1,097 | 1,128 | 1,360 | 1,532 | 1,703 | 1,907 |
| Net income 1 | 744.8 | 679.1 | 845 | 887.9 | 1,059 | 1,195 | 1,322 | 1,482 |
| Net Debt 1 | 779.2 | 1,236 | 493.9 | 579.3 | 667.8 | 395.5 | -144 | -647.3 |
| Reference price 2 | 658.46 | 407.96 | 555.05 | 413.44 | 676.53 | 676.04 | 676.04 | 676.04 |
| Nbr of stocks (in thousands) | 84,794 | 82,817 | 83,052 | 81,885 | 79,851 | 78,786 | - | - |
| Announcement Date | 2/2/22 | 6/2/23 | 5/2/24 | 3/2/25 | 2/2/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 36.37x | 4.28x | 16.09x | 2.36% | 190B | |
| 22.04x | 3.74x | 13.39x | 2.79% | 125B | |
| 28.1x | 4.99x | 17.09x | 1.11% | 124B | |
| 34.01x | 3.25x | 13.13x | 2.1% | 99.31B | |
| 17.69x | 0.21x | 13.23x | 0.71% | 63.65B | |
| 43.19x | 3.82x | 12.99x | 1.97% | 57.71B | |
| 44.96x | 11.29x | 31.68x | -.--% | 53.26B | |
| 26.93x | 6.63x | 16.85x | 1.5% | 47.03B | |
| 44.32x | 3.5x | 13.01x | 0.49% | 36.15B | |
| Average | 33.07x | 4.63x | 16.38x | 1.45% | 88.46B | |
| Weighted average by Cap. | 31.92x | 4.39x | 15.95x | 1.75% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- IDXX Stock
- I1DX34 Stock
- Valuation IDEXX Laboratories, Inc.
Select your edition
All financial news and data tailored to specific country editions
